Remove Disease Remove Drug Trials Remove Pharmacokinetics Remove Regulations
article thumbnail

What are the top disease areas for clinical drug trials?

Drug Discovery World

Breast cancer retained its position as the most-studied disease area in clinical trials in 2022, according to a recent report by analytics company Phesi. Here, we take a look at the top four disease areas and some of the key developments in 2022. The post What are the top disease areas for clinical drug trials?

Trials 130
article thumbnail

Advanced 3D cell-based technologies

Drug Target Review

This major shift to the orthodox tradition of using animal experiments in drug testing dates back the Aristotle’s time and cemented 80 years ago with initial federal mandate of drug safety regulation of 1938.

article thumbnail

How Improving Diversity Can Benefit Clinical Trials

Alta Sciences

Why Diversity in Clinical Trials Matters A wide variety of factors, from age or biological sex to environmental conditions and lifestyle choices (e.g., substance abuse, sexual activity), can influence the risk and likelihood of developing a disease or other long-term health issues—as well as the way an individual responds to treatment.